Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
918,976
-
Shares change
-
+984
-
Total reported value, excl. options
-
$31,685,000
-
Value change
-
+$34,128
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$34.48
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q4 2016
11 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q4 2016.
NOVOZYMES A S DKK 2.0 - COM has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 918,976 shares
.
Largest 10 shareholders include SOMERVILLE KURT F (244,325 shares), Hemenway Trust Co LLC (181,515 shares), Kidder Stephen W (117,415 shares), Broderick Brian C (109,307 shares), PUZO MICHAEL J (82,770 shares), Page Arthur B (45,080 shares), Notis-McConarty Edward (33,481 shares), Fayerweather Charles (28,080 shares), Delaney Dennis R (27,403 shares), and Dempze Nancy E (25,935 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.